FIELD: medicine.
SUBSTANCE: invention concerns a tablet containing fluvastatin with sodium carboxymethylcellulose of calcium in the form of raising agent. The fluvastatin tablet is characterised by time of disintegration from 10 to 30 minutes and good bioavailability equivalent to bioavailability of serially produced capsules, containing fluvastatin. Manufacturing of tablets does peroral application of fluvastatin economically more favourable and more convenient for patients.
EFFECT: rising of profitability and convenience of peroral fluvastatin application to patients.
12 cl, 7 dwg, 6 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2470637C2 |
PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2121835C1 |
STABLE PHARMACEUTICAL COMPOSITION CONTAINING WATER-SOLUBLE VINFLUNINE SALT | 2008 |
|
RU2462248C2 |
PHARMACEUTICAL COMPOSITION CONTAINING QUINOLINE DERIVATIVE | 2010 |
|
RU2548673C2 |
PHARMACEUTICAL PREPARATION | 2020 |
|
RU2822063C2 |
PHARMACEUTICAL COMPLEX FORMULATION COMPRISING ANGIOTENSIN II RECEPTOR BLOCKER AND HMG-CoA REDUCTASE INHIBITOR | 2014 |
|
RU2662565C2 |
PHOSPHATE ADSORBENT BASED ON IRON (III) COMPOUNDS AND CARBOHYDRATES | 2007 |
|
RU2447933C2 |
PHARMACOLOGICAL COMPOSITION WITH SWELLING COATING | 2004 |
|
RU2375048C2 |
STABLE PHARMACEUTICAL COMPOSITION OF WATER-SOLUBLE SALT OF VINORELBINE | 2008 |
|
RU2476208C2 |
CAPSULE COMPOSITION | 2013 |
|
RU2642934C2 |
Authors
Dates
2009-07-20—Published
2004-06-24—Filed